Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-07-11

Clinical Trial Update: A Multicentre Trial to Determine the Efficacy and Safety of Milnacipran in the Treatment of Fibromyalgia Syndrome [Phase 3]

View source ↗

Summary

Phase 3 multicenter trial evaluating the efficacy and safety of milnacipran for fibromyalgia; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Milnacipran (milnacipran)

Snippet

Sponsor: Pierre Fabre Medicament | Conditions: Fibromyalgia Syndrome | Phase 3 | Status: COMPLETED